PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1398764
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1398764
A recent analysis report by Fairfield Market Research reveals that the global Non-PVC IV Bags market achieved a sales figure of US$ 2.2 billion in 2024 and is anticipated to reach a substantial valuation of US$ 6 billion by 2031. The Single Chamber segment is expected to lead in revenue generation from 2024 to 2031.
Non-PVC IV bags have gained prominence primarily in parenteral feeding and chemotherapy applications. Their versatility extends to various applications, including cold and frozen storage, contributing to their increasing demand. Stringent regulatory standards associated with PVC IV bags have led to the growing adoption of non-PVC materials across medical and non-medical industries. This global shift away from PVC materials presents significant growth opportunities, attracting both manufacturers and investors.
In the realm of parenteral feeding services, the utilization of non-PVC IV bags is on the rise. As patient requirements for composition vary, the demand for multi-chambered containers is growing. This trend is expected to further drive the need for customized IV bag providers with the introduction of more specialized therapeutic solutions.
North America currently holds the largest share of the global Non-PVC IV Bags market. Several factors contribute to this, including proactive measures taken by authorities, stricter regulatory oversight for patient well-being, increased research spending, rising cases of conditions such as cancer and diarrhea, and the presence of numerous market players. Additionally, stringent regulations aimed at enhancing patient safety and the growing demand for Eva infusion bags are expected to fuel the demand for non-PVC IV bags in the region.
By the end of 2031, the United States is poised to lead the Non-PVC IV Bags market with the largest market share. It had previously experienced significant growth at a notable CAGR from 2018 to 2022, and this upward trajectory is expected to continue with a robust CAGR throughout the forecasted period.
In North America, the United States dominates the Non-PVC IV Bags Market share. Moreover, the country's market is set to be invigorated by the increasing utilization of innovative medication delivery technologies and ongoing technological advancements.
The Non-PVC IV Bags market in the United Kingdom is anticipated to achieve a valuation milestone by 2033. It is projected to grow steadily, with a notable CAGR from 2024 to 2031. During this forecasted period, the market is poised to create a substantial absolute dollar opportunity.
In Japan, the Non-PVC IV Bags market is expected to attain a significant valuation by 2031. Over the course of the forecast period, the market in Japan is poised to accumulate a substantial absolute dollar opportunity, while experiencing substantial growth at a robust CAGR.
The Non-PVC IV Bags market in South Korea is on a path of substantial growth, projected to maintain a noteworthy CAGR from 2024 to 2031. During this timeframe, the market is expected to witness a considerable absolute dollar opportunity, reaching a significant valuation by 2031.
Key players in the Non-PVC IV Bags Market include: Baxter, B. Braun Melsungen AG, Pfizer, Inc., Fresenius Kabi AG, JW Life Science, RENOLIT, PolyCine GmbH, Sealed Air, ANGIPLAST PVT. LTD, Shanghai Solve Care Co Ltd., Kraton Corporation, and Jiangxi Sanxin Medtec Co., Ltd.